Skip to main content
. Author manuscript; available in PMC: 2011 Jul 11.
Published in final edited form as: Cancer Res. 2010 May 25;70(12):5116–5126. doi: 10.1158/0008-5472.CAN-09-4368

Figure 2. Implication of PTPL1 in breast cancer cells aggressiveness.

Figure 2

A, Expression of PTPL1 in stable cell clones was monitored by western blot using anti-PTPL1 antibodies. The loading control was obtained by re-probing the membrane with anti-actin. B, Six-week-old mice were injected with clonal cell lines in the mammary glands. Tumor volume was measured at the indicated time, and the mean ± 95% confidence interval is shown (n=11 per group). *P<0.0012 for mean of PTPL1-shRNAs versus mean of control-shRNAs (Student’s t-test).